Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi Sarode

Showing results (81-90 of 127) with videos related to

Pageof 13
Sort By:
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 24, 2018
Identifying Additional Risk Factors for Thrombosis and Pregnancy Morbidities Among Antiphospholipid Antibodies CarriersYu Zuo, Jennifer Fan, Ravi Sarode, et al.
Blood Advances|December 27, 2022
INR and vitamin K-dependent factor levels after vitamin K antagonist reversal with 4F-PCC or plasmaChristopher Hood, Joshua N Goldstein, Truman J Milling, et al.
Journal of Clinical Apheresis|March 1, 2021
Immune checkpoint inhibitor toxicity: A new indication for therapeutic plasma exchange?Frances Compton, Lin He, Ravi Sarode, et al.
Journal of Clinical Apheresis|November 3, 2018
Single-needle: an effective alternative to dual-needle peripheral access in therapeutic plasma exchangeBetty M Doggett, Nellie Session-Augustine, Joseph Roig, et al.
The American Journal of Cardiology|January 4, 2016
Differences in Whole Blood Platelet Aggregation at Baseline and in Response to Aspirin and Aspirin Plus Clopidogrel in Patients With Versus Without Chronic Kidney DiseaseNishank Jain, Xilong Li, Beverley Adams-Huet, et al.
Transfusion|July 3, 2015
Increased risk of volume overload with plasma compared with four-factor prothrombin complex concentrate for urgent vitamin K antagonist reversalMajed A Refaai, Joshua N Goldstein, Martin L Lee, et al.
Circulation|August 13, 2013
Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb studyRavi Sarode, Truman J Milling, Majed A Refaai, et al.
Blood Advances|August 12, 2020
Physical activity in children at risk of postthrombotic sequelae: a pilot randomized controlled trialRida Hasan, Maria Hanna, Song Zhang, et al.
Blood Vessels, Thrombosis & Hemostasis|August 6, 2025
Tailoring caplacizumab administration using ADAMTS13 activity for immune-mediated thrombotic thrombocytopenic purpuraSean G Yates, Sandra L Hofmann, Ibrahim F Ibrahim, et al.
Plos One|May 14, 2016
Analysis of Thrombophilia Test Ordering Practices at an Academic Center: A Proposal for Appropriate Testing to Reduce Harm and CostYu-Min Shen, Judy Tsai, Evelyn Taiwo, et al.
Pageof 13

Showing results (81-90 of 127) with videos related to

Sort By:
Pageof 13
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 24, 2018
Identifying Additional Risk Factors for Thrombosis and Pregnancy Morbidities Among Antiphospholipid Antibodies CarriersYu Zuo, Jennifer Fan, Ravi Sarode, et al.
Blood Advances|December 27, 2022
INR and vitamin K-dependent factor levels after vitamin K antagonist reversal with 4F-PCC or plasmaChristopher Hood, Joshua N Goldstein, Truman J Milling, et al.
Journal of Clinical Apheresis|March 1, 2021
Immune checkpoint inhibitor toxicity: A new indication for therapeutic plasma exchange?Frances Compton, Lin He, Ravi Sarode, et al.
Journal of Clinical Apheresis|November 3, 2018
Single-needle: an effective alternative to dual-needle peripheral access in therapeutic plasma exchangeBetty M Doggett, Nellie Session-Augustine, Joseph Roig, et al.
The American Journal of Cardiology|January 4, 2016
Differences in Whole Blood Platelet Aggregation at Baseline and in Response to Aspirin and Aspirin Plus Clopidogrel in Patients With Versus Without Chronic Kidney DiseaseNishank Jain, Xilong Li, Beverley Adams-Huet, et al.
Transfusion|July 3, 2015
Increased risk of volume overload with plasma compared with four-factor prothrombin complex concentrate for urgent vitamin K antagonist reversalMajed A Refaai, Joshua N Goldstein, Martin L Lee, et al.
Circulation|August 13, 2013
Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb studyRavi Sarode, Truman J Milling, Majed A Refaai, et al.
Blood Advances|August 12, 2020
Physical activity in children at risk of postthrombotic sequelae: a pilot randomized controlled trialRida Hasan, Maria Hanna, Song Zhang, et al.
Blood Vessels, Thrombosis & Hemostasis|August 6, 2025
Tailoring caplacizumab administration using ADAMTS13 activity for immune-mediated thrombotic thrombocytopenic purpuraSean G Yates, Sandra L Hofmann, Ibrahim F Ibrahim, et al.
Plos One|May 14, 2016
Analysis of Thrombophilia Test Ordering Practices at an Academic Center: A Proposal for Appropriate Testing to Reduce Harm and CostYu-Min Shen, Judy Tsai, Evelyn Taiwo, et al.
Pageof 13